SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Pappas Ventures names Michael Grey Venture Partner
News | 01. 11. 2010
Pappas Ventures today announced that industry veteran Michael Grey has been named a venture partner.
